Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Miller Children's Hosp. Long Beach CA NICHD CRS
mi
from
Long Beach, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Miller Children's Hosp. Long Beach CA NICHD CRS
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Children's Hospital of Los Angeles NICHD CRS
mi
from
Los Angeles, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Children's Hospital of Los Angeles NICHD CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS
mi
from
Los Angeles, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
University of California, UC San Diego CRS
mi
from
San Diego, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
University of California, UC San Diego CRS
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Univ. of California San Francisco NICHD CRS
mi
from
San Francisco, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Univ. of California San Francisco NICHD CRS
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Harbor UCLA Medical Center NICHD CRS
mi
from
Torrance, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Harbor UCLA Medical Center NICHD CRS
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Univ. of Colorado Denver NICHD CRS
mi
from
Aurora, CO
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Univ. of Colorado Denver NICHD CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Children's National Med. Ctr. Washington DC NICHD CRS
mi
from
Washington,
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Children's National Med. Ctr. Washington DC NICHD CRS
mi
from
Washington,
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Howard Univ. Washington DC NICHD CRS
mi
from
Washington,
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Howard Univ. Washington DC NICHD CRS
mi
from
Washington,
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
South Florida CDTC Ft Lauderdale NICHD CRS
mi
from
Fort Lauderdale, FL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
South Florida CDTC Ft Lauderdale NICHD CRS
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Univ. of Florida Jacksonville NICHD CRS
mi
from
Jacksonville, FL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Univ. of Florida Jacksonville NICHD CRS
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Pediatric Perinatal HIV Clinical Trials Unit CRS
mi
from
Miami, FL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Pediatric Perinatal HIV Clinical Trials Unit CRS
mi
from
Miami, FL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
USF - Tampa NICHD CRS
mi
from
Tampa, FL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
USF - Tampa NICHD CRS
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Rush Univ. Cook County Hosp. Chicago NICHD CRS
mi
from
Chicago, IL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Rush Univ. Cook County Hosp. Chicago NICHD CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS
mi
from
Chicago, IL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Tulane Univ. New Orleans NICHD CRS
mi
from
New Orleans, LA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Tulane Univ. New Orleans NICHD CRS
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Univ. of Maryland Baltimore NICHD CRS
mi
from
Baltimore, MD
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Univ. of Maryland Baltimore NICHD CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Children's Hosp. of Boston NICHD CRS
mi
from
Boston, MA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Children's Hosp. of Boston NICHD CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Boston Medical Center Ped. HIV Program NICHD CRS
mi
from
Boston, MA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Boston Medical Center Ped. HIV Program NICHD CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
WNE Maternal Pediatric Adolescent AIDS CRS
mi
from
Worcester, MA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
WNE Maternal Pediatric Adolescent AIDS CRS
mi
from
Worcester, MA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Children's Hospital of Michigan NICHD CRS
mi
from
Detroit, MI
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Children's Hospital of Michigan NICHD CRS
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Rutgers - New Jersey Medical School CRS
mi
from
Newark, NJ
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Rutgers - New Jersey Medical School CRS
mi
from
Newark, NJ
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Bronx-Lebanon CRS
mi
from
Bronx, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Bronx-Lebanon CRS
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Jacobi Med. Ctr. Bronx NICHD CRS
mi
from
Bronx, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Jacobi Med. Ctr. Bronx NICHD CRS
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Nyu Ny Nichd Crs
mi
from
New York, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Nyu Ny Nichd Crs
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Metropolitan Hosp. NICHD CRS
mi
from
New York, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Metropolitan Hosp. NICHD CRS
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Columbia IMPAACT CRS
mi
from
New York, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Columbia IMPAACT CRS
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Strong Memorial Hospital Rochester NY NICHD CRS
mi
from
Rochester, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Strong Memorial Hospital Rochester NY NICHD CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
SUNY Stony Brook NICHD CRS
mi
from
Stony Brook, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
SUNY Stony Brook NICHD CRS
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
DUMC Ped. CRS
mi
from
Durham, NC
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
DUMC Ped. CRS
mi
from
Durham, NC
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
The Children's Hosp. of Philadelphia IMPAACT CRS
mi
from
Philadelphia, PA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
The Children's Hosp. of Philadelphia IMPAACT CRS
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
St. Jude Children's Research Hospital CRS
mi
from
Memphis, TN
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
St. Jude Children's Research Hospital CRS
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Texas Children's Hosp. CRS
mi
from
Houston, TX
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Texas Children's Hosp. CRS
mi
from
Houston, TX
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Seattle Children's Research Institute CRS
mi
from
Seattle, WA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Seattle Children's Research Institute CRS
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
University of Puerto Rico Pediatric HIV/AIDS Research Program CRS
mi
from
San Juan,
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
University of Puerto Rico Pediatric HIV/AIDS Research Program CRS
mi
from
San Juan,
Click here to add this to my saved trials
Network Supported Engagement In HIV Care
Network Supported Engagement In HIV Care
Status: Enrolling
Updated:  1/13/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Network Supported Engagement In HIV Care
Network Supported Engagement In HIV Care
Status: Enrolling
Updated: 1/13/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Expansion to Interdisciplinary HIV Prevention in Women
Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women
Status: Enrolling
Updated:  1/13/2016
University of Oklahoma
mi
from
Oklahoma City, OK
Expansion to Interdisciplinary HIV Prevention in Women
Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women
Status: Enrolling
Updated: 1/13/2016
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Expansion to Interdisciplinary HIV Prevention in Women
Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women
Status: Enrolling
Updated:  1/13/2016
St. Petersburg State University
mi
from
St. Peterburg,
Expansion to Interdisciplinary HIV Prevention in Women
Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women
Status: Enrolling
Updated: 1/13/2016
St. Petersburg State University
mi
from
St. Peterburg,
Click here to add this to my saved trials
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
Status: Enrolling
Updated:  1/15/2016
LA County Jail
mi
from
Los Angeles, CA
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
Status: Enrolling
Updated: 1/15/2016
LA County Jail
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Southwest Center for HIV/AIDS
mi
from
Phoenix, AZ
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Southwest Center for HIV/AIDS
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Health for Life Clinic, PLLC
mi
from
Little Rock, AR
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Health for Life Clinic, PLLC
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
AIDS Healthcare Foundation-Research Center
mi
from
Beverly HIlls, CA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
AIDS Healthcare Foundation-Research Center
mi
from
Beverly HIlls, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Living Hope Foundation
mi
from
Long Beach, CA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Living Hope Foundation
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Peter J. Ruane, MD, Inc.
mi
from
Los Angeles, CA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Peter J. Ruane, MD, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Orange Coast Medical Group
mi
from
Newport Beach, CA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Orange Coast Medical Group
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
David J. Shamblaw, MD Inc.
mi
from
San Diego, CA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
David J. Shamblaw, MD Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Metropolis Medical
mi
from
San Francisco, CA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Metropolis Medical
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Denver Infectious Disease Consultants, PLLC
mi
from
Denver, CO
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Denver Infectious Disease Consultants, PLLC
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Dupont Circle Physician's Group
mi
from
Washington,
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Dupont Circle Physician's Group
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Whitman Walker Clinic
mi
from
Washington,
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Whitman Walker Clinic
mi
from
Washington,
Click here to add this to my saved trials